Fortrea Posts Loss In Q4; To Divest Endpoint Clinical And Pa

Fortrea Posts Loss In Q4; To Divest Endpoint Clinical And Patient Access Businesses

Fortrea (FTRE) posted a fourth quarter GAAP net loss of $36.0 million and loss per share of $0.41 compared to net income of $33.4 million and earnings per share of $0.

Related Keywords

, Thomson Reuters , Enabling Services , Endpoint Clinical , Fortrea Patient Access , Arsenal Capital ,